|
|

|
|
| |
|
Send this page to a friend
|
Coverage of CROI 2008 (Conference on Retroviruses and Opportunistic
Infections)
February 4–6, 2008, Boston, MA
Approved HIV treatments
02.05.08 |
Viramune: maybe twice a day, maybe once a day |
02.05.08 |
Truvada appears to improve limb fat loss |
02.05.08 |
Best use of Selzentry still in question |
02.04.08 |
SMART study reports on re-starting ART |
02.04.08 |
CASTLE study compares Reyataz to Kaletra |
02.04.08 |
HEAT study shows Epzicom as good as Truvada when paired
with Kaletra |
02.04.08 |
Study finds heart trouble with Ziagen and Videx |
Experimental HIV treatments
02.12.08 |
Stem cells: Progress towards “the cure”? |
02.05.08 |
Experimental NtRTI may cause fewer kidney problems |
02.05.08 |
Apricitabine shows some promise |
02.04.08 |
VICTOR-E1 study results raise more questions about vicriviroc |
02.05.08 |
Assessment of HIV vaccine research discouraging |
Complications and side effects
02.06.08 |
Several studies reveal sobering information on genital
herpes and HIV |
02.06.08 |
Bone loss remains an issue for people taking HIV drugs |
02.04.08 |
Study finds heart trouble with Ziagen and Videx |
|
IN THE NEWS
ARCHIVES
2008 2007 2006
CONFERENCE
COVERAGE
2008 CROI
2007 ICAAC
2007 IAS
2007 CROI
2006 Int'l Conference
PROJECT INFORM
CITED IN MEDIA
2008 2007
|
|
| |
|
|
|
| |
© 2008 Project Inform 1375 Mission
Street, San Francisco, CA 94103 415-558-8669
National HIV/AIDS Treatment Hotline 1-800-822-7422 (415-558-9051 local/int'l) 10a-4p Mon-Fri PST
|
|
|